The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
Open accessAbstract
Purpose: Low muscle mass is present in approximately 40% of patients with metastatic colorectal cancer (mCRC) and may be associated with poor outcome. We studied change in skeletal muscle during palliative chemotherapy in patients with mCRC and its association with treatment modifications and overall survival. Patients and Methods: In 67 patients with mCRC (mean age ± standard deviation, 66.4 ± 10.6 years; 63% male), muscle area (square centimeters) was assessed using computed tomography scans of the third lumbar vertebra before and during palliative chemotherapy. Treatment modifications resulting from toxicity were evaluated, including delay, dose reduction, or termination of chemotherapy. Multiple regression analyses were performed for the association between change in muscle area and treatment modification and secondly overall survival. Results: Muscle area of patients with mCRC decreased significantly during 3 months of chemotherapy by 6.1% (95% CI, −8.4 to −3.8; P < .001). Change in muscle area was not associated with treatment modifications. However, patients with muscle loss during treatment of 9% or more (lowest tertile) had significantly lower survival rates than patients with muscle loss of less than 9% (at 6 months, 33% v 69% of patients alive; at 1 year, 17% v 49% of patients alive; log-rank P = .001). Muscle loss of 9% or more remained independently associated with survival when adjusted for sex, age, baseline lactate dehydrogenase concentration, comorbidity, mono-organ or multiorgan metastases, treatment line, and tumor progression at first evaluation by computed tomography scan (hazard ratio, 4.47; 95% CI, 2.21 to 9.05; P < .001). Conclusion: Muscle area decreased significantly during chemotherapy and was independently associated with survival in patients with mCRC. Further clinical evaluation is required to determine whether nutritional interventions and exercise training may preserve muscle area and thereby improve outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
Mitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522
Aging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-009-0110-5 · Cited by 1,352
Courneya, K. S., Segal, R. J., Mackey, J. R., Gelmon, K., Reid, R. D., Friedenreich, C. M., Ladha, A. B., Proulx, C., Vallance, J. K. H., Lane, K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2024 · Cited by 1,179
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,104
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K., Arends, J., & Baracos, V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 940
Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.007 · Cited by 938
Dietary protein recommendations and the prevention of sarcopenia
Paddon-Jones, D., & Rasmussen, B. B. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831cef8b · Cited by 823
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 653
Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Mourtzakis, M., Mulder, K. E., Reiman, T., Butts, C. A., Scarfe, A. G., & Sawyer, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3067 · Cited by 619
Body composition and outcome in patients undergoing resection of colorectal liver metastases19
van Vledder, M. G., Levolger, S., Ayez, N., Verhoef, C., Tran, T. C. K., & IJzermans, J. N. M. (2012) · British Journal of Surgery · doi:10.1002/bjs.7823 · Cited by 462
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Awad, S., Tan, B. H., Cui, H., Bhalla, A., Fearon, K. C. H., Parsons, S. L., Catton, J. A., & Lobo, D. N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.08.008 · Cited by 269
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
Sabel, M. S., Lee, J., Cai, S., Englesbe, M. J., Holcombe, S., & Wang, S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1976-9 · Cited by 266
Lieffers, J. R., Mourtzakis, M., Hall, K. D., McCargar, L. J., Prado, C. M., & Baracos, V. E. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27273 · Cited by 251
Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
Barret, M., Antoun, S., Dalban, C., Malka, D., Mansourbakht, T., Zaanan, A., Latko, E., & Taieb, J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.894103 · Cited by 243
Prado, C. M., Sawyer, M. B., Ghosh, S., Lieffers, J. R., Esfandiari, N., Antoun, S., & Baracos, V. E. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.060228 · Cited by 228
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
Cassidy, J., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Rittweger, K., Gilberg, F., & Saltz, L. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.201 · Cited by 224
Antoun, S., Lanoy, E., Iacovelli, R., Albiges‐Sauvin, L., Loriot, Y., Merad‐Taoufik, M., Fizazi, K., di Palma, M., Baracos, V. E., & Escudier, B. (2013) · Cancer · doi:10.1002/cncr.28218 · Cited by 215
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
Stene, G. B., Helbostad, J. L., Amundsen, T., Sørhaug, S., Hjelde, H., Kaasa, S., & Grønberg, B. H. (2015) · Acta Oncologica · doi:10.3109/0284186x.2014.953259 · Cited by 210
Dietary protein and muscle in older persons
Paddon-Jones, D., & Leidy, H. (2014) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000011 · Cited by 204
Thoresen, L., Frykholm, G., Lydersen, S., Ulveland, H., Baracos, V., Prado, C. M. M., Birdsell, L., & Falkmer, U. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.05.009 · Cited by 185
Malietzis, G., Aziz, O., Bagnall, N. M., Johns, N., Fearon, K. C., & Jenkins, J. T. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2014.10.056 · Cited by 173
Prado, C. M. M., Bekaii‐Saab, T., Doyle, L. A., Shrestha, S., Ghosh, S., Baracos, V. E., & Sawyer, M. B. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.144 · Cited by 114
Barret, M., Malka, D., Aparicio, T., Dalban, C., Locher, C., Sabaté, J., Louafi, S., Mansourbakht, T., Bonnetain, F., Attar, A., et al. (2011) · Oncology · doi:10.1159/000335478 · Cited by 113
The advantages and limitations of cross-sectional body composition analysis
MacDonald, A. J., Greig, C. A., & Baracos, V. (2011) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e32834c49eb · Cited by 101
Loss of muscle mass in the end of life in patients with advanced cancer
Wallengren, O., Iresjö, B., Lundholm, K., & Bosaeus, I. G. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2332-y · Cited by 95
Sjøblom, B., Grønberg, B. H., Benth, J. Š., Baracos, V. E., Fløtten, Ø., Hjermstad, M. J., Aass, N., & Jordhøy, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.07.001 · Cited by 93
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0137-7 · Cited by 78
Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC
Zhang, H., & Garcia, J. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1041500 · Cited by 61
‘Pre-cachexia’: a non-existing phenomenon in cancer?
Blauwhoff-Buskermolen, S., de van der Schueren, M. A. E., Verheul, H. M. W., & Langius, J. A. E. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu178 · Cited by 31
Self-citationWhat does a patient's outfit weight?
Frank, E., & Dunlop, A. L. (2000) · PubMed · Cited by 30
Cited by
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Nutrition interventions to treat low muscle mass in cancer
Prado, C. M., Purcell, S. A., & Laviano, A. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12525 · Cited by 392
Ravasco, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081211 · Cited by 353
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
Aleixo, G. F. P., Shachar, S. S., Nyrop, K. A., Muss, H. B., Malpica, L., & Williams, G. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102839 · Cited by 345
Bozzetti, F. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx271 · Cited by 323
Metadata
- Authors
- Blauwhoff-Buskermolen, S., Versteeg, K. S., de van der Schueren, M. A. E., den Braver, N. R., Berkhof, J., Langius, J. A. E., & Verheul, H. M. W.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-04-20
- Volume
- 34
- Issue
- 12
- Pages
- 1339-1344
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2275733417
- Cited by
- 378
- References
- 39
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.